NNS 2026

Franklin Okumu

All Sessions by Franklin Okumu

5:15 pm - 7:00 pm

POB.158 - Fc-Engineered Monoclonal Antibodies Targeting neoGFAP™ as a Disease-Modifying Immunotherapy for Traumatic Brain Injury